Potential ototoxicity from triamcinolone, neomycin, gramicidin and nystatin (Tri-Adcortyl) cream
- PMID: 15807966
- DOI: 10.1258/0022215053222950
Potential ototoxicity from triamcinolone, neomycin, gramicidin and nystatin (Tri-Adcortyl) cream
Abstract
Although rare, ototoxicity from the use of aminoglycoside drops is well recognized. Ototoxicity has not been described with the use of combination aminoglycoside-steroid-antifungal creams or ointments. We present the case of a 60-year-old man with a perforated tympanic membrane who suffered a total hearing loss after the instillation of cream containing triamcinolone, neomycin, gramicidin and nystatin (Tri-Adcortyl cream) into his ear canal. On balance, we believe that a number of potentially ototoxic constituents in this cream were responsible. Other possible causes of sensorineural hearing loss and the possible mechanisms of ototoxicity of this cream are discussed. The reasons why such creams may be particularly ototoxic, compared with drops, are also considered. The authors caution against the use of such creams or ointments in the ear if there is any suspicion of a tympanic membrane perforation.
Similar articles
-
The significance of ethylenediamine hydrochloride dermatitis caused by a "generic" nystatin-triamcinolone II cream.Cutis. 1988 Apr;41(4):241. Cutis. 1988. PMID: 2452718
-
Allergy to Kenacomb cream.Med J Aust. 1986 Oct 6;145(7):361. doi: 10.5694/j.1326-5377.1986.tb113857.x. Med J Aust. 1986. PMID: 2429167 No abstract available.
-
Perfume dermatitis. Part III. The search for nonsensitizing perfumes.Cutis. 1981;27(1):13-7, 20-2, 62. Cutis. 1981. PMID: 6162615 No abstract available.
-
Ototoxicity of ear drops: a clinical perspective.Am J Otol. 1995 Sep;16(5):653-7. Am J Otol. 1995. PMID: 8588672 Review.
-
Ototoxicity of ototopical drops--an update.Otolaryngol Clin North Am. 2007 Jun;40(3):669-83, xi. doi: 10.1016/j.otc.2007.03.010. Otolaryngol Clin North Am. 2007. PMID: 17544701 Review.
Cited by
-
Clinical Pharmacogenetics Implementation Consortium Guideline for the Use of Aminoglycosides Based on MT-RNR1 Genotype.Clin Pharmacol Ther. 2022 Feb;111(2):366-372. doi: 10.1002/cpt.2309. Epub 2021 Jun 20. Clin Pharmacol Ther. 2022. PMID: 34032273 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Medical